Fish oil supplements lower the risk of heart disease—but only for patients with the right genetic makeup

Does taking fish oil supplements really lower a person’s risk of heart disease? Yes, according to a new analysis in PLOS Genetics — but that is not necessarily true for everyone.  

Researchers from the University of Georgia (UGA), Tulane University and Cornell University explored the topic at length.

“We've known for a few decades that a higher level of omega-3 fatty acids in the blood is associated with a lower risk of heart disease,” lead author Kaixiong Ye, PhD, an assistant professor of genetics in the Franklin College of Arts and Sciences at UGA, said in a prepared statement. “What we found is that fish oil supplementation is not good for everyone; it depends on your genotype.”

Ye et al. examined data from 70,000 patients who participated in the U.K. Biobank study. While approximately 11,000 participants were taking fish oil supplements, the remaining individuals were not.

The authors went on to run more than 64 million tests, finding that the GJB2 gene appeared to be a key piece of the equation. Participants with the AG genotype who took fish oil supplements achieved a decrease in their triglycerides — but not participants with the AA genotype who took fish oil supplements. In fact, the AA genotype was actually associated with a slight increase in triglycerides.   

Looking ahead, the researchers hope to learn more about how fish oil impacts patients with cardiovascular disease—when the patients has the correct genetic makeup, at least.

“Personalizing and optimizing fish oil supplementation recommendations based on a person’s unique genetic composition can improve our understanding of nutrition and lead to significant improvements in human health and well-being,” Ye said.

The full analysis can be read here.

 

Related fish oil content:

Fish oil supplements linked to potentially fatal heart rhythm issues

Fish oil supplements lower the risk of heart disease — but only for patients with the right genetic makeup

Omega-3 fatty acid supplements linked to a higher AFib risk, new meta-analysis confirms

Fish oil and vitamin D supplements don’t prevent atrial fibrillation

Latest fish oil analysis suggests omega-3s promote heart health

Fish oil supplements linked to potentially fatal heart rhythm issues

 

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.